Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Vivjoa. Always confirm against the full prescribing information.
100 interactions
Abemaciclib
The serum concentration of Abemaciclib can be increased when it is combined with Oteseconazole.
Level 1 evidence
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Oteseconazole.
Level 1 evidence
Allopurinol
The serum concentration of Allopurinol can be increased when it is combined with Oteseconazole.
Level 1 evidence
Almasilate
Almasilate can cause a decrease in the absorption of Oteseconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Alpelisib
The serum concentration of Alpelisib can be increased when it is combined with Oteseconazole.
Level 1 evidence
Aluminium phosphate
Aluminium phosphate can cause a decrease in the absorption of Oteseconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Aluminum hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Oteseconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Amphotericin B
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Oteseconazole.
Level 1 evidence
Apixaban
The serum concentration of Apixaban can be increased when it is combined with Oteseconazole.
Level 1 evidence
Asenapine
Asenapine can cause a decrease in the absorption of Oteseconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Atorvastatin
The risk or severity of myopathy can be increased when Oteseconazole is combined with Atorvastatin.
Level 1 evidence
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Oteseconazole.
Level 1 evidence
Enter your NPI to unlock 1 major interaction for Vivjoa
Vivjoa (Oteseconazole) has 141 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Vivjoa (Oteseconazole) has 2 major, 116 moderate, and 23 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Vivjoa. Always confirm against the full prescribing information.